TrialDrug design, development and therapy2023

Comparative Pharmacokinetics and Bioequivalence Evaluation of Two Formulations of Pramipexole Dihydrochloride Extended-Release Tablets in Healthy Chinese Subjects Under Fasted and Fed States: A Randomized, Open-Label, Single-Dose, Two-Period Crossover Clinical Trial.

Ling Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.